Leyla Bayat, MD (@leylakbayat) 's Twitter Profile
Leyla Bayat, MD

@leylakbayat

Hematology and Oncology Fellow, NYU Grossman School of Medicine

ID: 1506081510184693768

calendar_today22-03-2022 01:33:23

4 Tweet

24 Followers

21 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
The ASCO Post (@ascopost) 's Twitter Profile Photo
The ASCO Post
@ascopost

3 years ago

Exploratory Analysis of POSEIDON: Chemoimmunotherapy Regimen May Offer Survival Benefit in Subgroups of Metastatic NSCLC ascopost.com/issues/septemb… #WCLC22 #WCLC2022 #LCSM #lungcancer #oncology #immunotherapy

ASCO (@asco) 's Twitter Profile Photo
ASCO
@asco

3 years ago

Now live‼️ To honor #WHPCDay22 & #BreastCancerAwarenessMonth, we're pleased to partner on this webinar series that offers global perspectives on transforming survivorship & palliative care in #breastcancer. Watch: fal.cn/3svC0 #pallonc #bcsm #survonc #hapc #hpm

The ASCO Post (@ascopost) 's Twitter Profile Photo
The ASCO Post
@ascopost

3 years ago

Addition of PD-1 Inhibitor Serplulimab to Chemotherapy in the First-Line Treatment of Extensive-Stage SCLC ascopost.com/news/october-2… #LCSM #lungcancer #oncology #immunotherapy

Perlmutter Cancer Center at NYU Langone Health (@perlmutter_cc) 's Twitter Profile Photo
Perlmutter Cancer Center at NYU Langone Health
@perlmutter_cc

3 years ago

Medical oncologist Dr. Sylvia Adams talks to CBS New York about the advances in treatment of triple-negative breast cancer. 🔗 bit.ly/3DOX1U2

Medical oncologist Dr. Sylvia Adams talks to <a href="/CBS/">CBS</a> New York about the advances in treatment of triple-negative breast cancer. 🔗 bit.ly/3DOX1U2